These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7818725)

  • 1. Reduction of the acute bioavailability of metformin by the alpha-glucosidase inhibitor acarbose in normal man.
    Scheen AJ; de Magalhaes AC; Salvatore T; Lefebvre PJ
    Eur J Clin Invest; 1994 Aug; 24 Suppl 3():50-4. PubMed ID: 7818725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
    Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
    J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance.
    Chiasson JL; Josse RG; Leiter LA; Mihic M; Nathan DM; Palmason C; Cohen RM; Wolever TM
    Diabetes Care; 1996 Nov; 19(11):1190-3. PubMed ID: 8908378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of miglitol and acarbose after an oral glucose load: a novel hypoglycaemic mechanism?
    Joubert PH; Venter HL; Foukaridis GN
    Br J Clin Pharmacol; 1990 Sep; 30(3):391-6. PubMed ID: 2223417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acarbose treatment of sulfonylurea-treated non-insulin dependent diabetics. A double-blind cross-over comparison of an alpha-glucosidase inhibitor with metformin.
    Johansen K
    Diabete Metab; 1984 Oct; 10(4):219-23. PubMed ID: 6391973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of acarbose in patients with cystic fibrosis and impaired glucose tolerance.
    Kentrup H; Bongers H; Spengler M; Kusenbach G; Skopnik H
    Eur J Pediatr; 1999 Jun; 158(6):455-9. PubMed ID: 10378391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of acarbose and voglibose in healthy subjects.
    Kageyama S; Nakamichi N; Sekino H; Nakano S
    Clin Ther; 1997; 19(4):720-9. PubMed ID: 9377616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of absorption of digoxin by acarbose.
    Miura T; Ueno K; Tanaka K; Sugiura Y; Mizutani M; Takatsu F; Takano Y; Shibakawa M
    J Clin Pharmacol; 1998 Jul; 38(7):654-7. PubMed ID: 9702852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small weight loss on long-term acarbose therapy with no change in dietary pattern or nutrient intake of individuals with non-insulin-dependent diabetes.
    Wolever TM; Chiasson JL; Josse RG; Hunt JA; Palmason C; Rodger NW; Ross SA; Ryan EA; Tan MH
    Int J Obes Relat Metab Disord; 1997 Sep; 21(9):756-63. PubMed ID: 9376887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method.
    Radziuk J; Kemmer F; Morishima T; Berchtold P; Vranic M
    Diabetes; 1984 Mar; 33(3):207-13. PubMed ID: 6365657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of acarbose and simultaneous antacid therapy on blood glucose.
    Höpfner M; Durani B; Spengler M; Fölsch UR
    Arzneimittelforschung; 1997 Oct; 47(10):1108-11. PubMed ID: 9368703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: dose-time-response relationships in man.
    Hillebrand I; Boehme K; Frank G; Fink H; Berchtold P
    Res Exp Med (Berl); 1979 Apr; 175(1):87-94. PubMed ID: 375343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acarbose: an alpha-glucosidase inhibitor.
    Martin AE; Montgomery PA
    Am J Health Syst Pharm; 1996 Oct; 53(19):2277-90; quiz 2336-7. PubMed ID: 8893066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.
    Derosa G; Franzetti I; Querci F; D'Angelo A; Maffioli P
    Pharmacotherapy; 2015 Nov; 35(11):983-90. PubMed ID: 26598090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of oral sucrose load during exercise in humans. Effect of the alpha-glucosidase inhibitor acarbose.
    Gerard J; Jandrain B; Pirnay F; Pallikarakis N; Krzentowski G; Lacroix M; Mosora F; Luyckx AS; Lefèbvre PJ
    Diabetes; 1986 Nov; 35(11):1294-301. PubMed ID: 3530858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of alpha-inhibitors on blood glucose and insulin levels.
    Laube H; Federlin K; Hillebrand I
    Adv Exp Med Biol; 1988; 246():287-93. PubMed ID: 3074658
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacology of alpha-glucosidase inhibition.
    Bischoff H
    Eur J Clin Invest; 1994 Aug; 24 Suppl 3():3-10. PubMed ID: 8001624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acarbose on carbohydrate tolerance during administration of a fibre-free formula diet on healthy subjects.
    Walter-Sack IE; Ittner-Holland A; Wolfram G; Zoellner N
    Eur J Clin Pharmacol; 1986; 30(5):607-14. PubMed ID: 3019703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man.
    Hillebrand I; Boehme K; Frank G; Fink H; Berchtold P
    Res Exp Med (Berl); 1979 Apr; 175(1):81-6. PubMed ID: 375342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fate and effects of the alpha-glucosidase inhibitor acarbose in humans. An intestinal slow-marker perfusion study.
    Ruppin H; Hagel J; Feuerbach W; Schutt H; Pichl J; Hillebrand I; Bloom S; Domschke W
    Gastroenterology; 1988 Jul; 95(1):93-9. PubMed ID: 3286363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.